Your browser doesn't support javascript.
loading
Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.
Ammitzbøll, Cecilie; Börnsen, Lars; Petersen, Eva Rosa; Oturai, Annette Bang; Søndergaard, Helle Bach; Grandjean, Philippe; Sellebjerg, Finn.
Afiliação
  • Ammitzbøll C; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: cecilie.ammitzboell@regionh.dk.
  • Börnsen L; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Petersen ER; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Oturai AB; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Søndergaard HB; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Grandjean P; Institute of Public Health, University of Southern Denmark, Odense, Denmark; Department of Environmental Health, Harvard School of Public Health, Boston, MA, United States.
  • Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
J Neuroimmunol ; 330: 90-95, 2019 05 15.
Article em En | MEDLINE | ID: mdl-30852181
ABSTRACT
Perfluorinated alkylated substances (PFASs) have immunomodulatory effects but the impact on multiple sclerosis (MS) and cellular immune functions is only sparsely described. In the present study, we found lower concentrations of the long chain PFAS perfluorooctane sulfonic acid (PFOS) in MS than in healthy controls (HC). In HC, we did not detect associations between PFOS concentrations and immune phenotypes. Analyzing the impact of known MS risk factors on cellular immune functions, we found that smoking and Epstein-Barr nuclear antigen 1 antibodies were associated with distinct circulating immune cell changes. In summary, current background PFAS exposure is not an important risk factor for MS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Alcanossulfônicos / Fluorocarbonos / Imunidade Celular / Esclerose Múltipla Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Alcanossulfônicos / Fluorocarbonos / Imunidade Celular / Esclerose Múltipla Idioma: En Ano de publicação: 2019 Tipo de documento: Article